awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37958038-1BA88948-E977-4E03-BD69-2043B544DEE5
Q37958038-1BA88948-E977-4E03-BD69-2043B544DEE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37958038-1BA88948-E977-4E03-BD69-2043B544DEE5
Progress and contrasts of the development of tivozanib for therapy of kidney cancer.
P2860
Q37958038-1BA88948-E977-4E03-BD69-2043B544DEE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37958038-1BA88948-E977-4E03-BD69-2043B544DEE5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
078d8bceb3a64589a1118195d271c1878d4f7305
P2860
Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers.